公司资料

Advaxis 股价、新闻与催化剂

股票代码:
ADXS
交易所:
NASDAQ
行业:
Biopharma
所在地:
United States

股价为何变动

Current closing-price context is not available for ADXS.

公司概览

业务概览

Advaxis was an immuno-oncology company focused on engineered immune therapies and antigen delivery before its restructuring and public-market decline. Its platform was rooted in cancer immunotherapy.

所在地与行业分类

Headquartered in the United States and formerly listed on NASDAQ, Advaxis sat in oncology biotechnology.

商业模式特征

The business depended on clinical development, platform validation, and strategic financing decisions.

生物医药行业定位

Advaxis belongs to the historical oncology-biotech set rather than the current live public-company universe.

未来催化剂

    近期新闻

      相似股票

      商业成熟度、治疗领域或催化剂模式相近的同行公司。